New Guidelines: Breast Cancer Prevention Drugs Everyday Health MenuNewslettersSearch Breast Cancer News Breast Cancer Prevention Drugs Recommended for Healthy High-Risk WomenNew guidelines suggest that tamoxifen, raloxifene, or aromatase inhibitors be prescribed for women at an increased risk of breast cancer but with no personal history. By Catherine PearsonMedically Reviewed by Thomas Urban Marron, MD, PhDOctober 4, 2019Everyday Health ArchiveMedically ReviewedEstrogen-blocking medications called aromatase inhibitors were added to the U.S. Preventive Services Task Force’s list of drugs believed to help reduce women’s breast cancer risk. Getty ImagesHealthy women who have known risk factors for developing breast cancer should talk to their doctor about taking medication to prevent the disease, says a new recommendation from a national panel of health experts. The new guidelines from the U.S. Preventive Services Task Force (USPSTF) recommend that clinicians consider prescribing tamoxifen (Soltamox), raloxifene (Evista), or aromatase inhibitors to women age 35 and up who are at higher than average risk for breast cancer. What degree of risk warrants preventive medication must be determined by a woman and her doctor. Among the factors that will be considered include family history, genetics, and whether you have dense breast tissue. New Guidelines Add Another Category of Drugs to the Options The new recommendations — which were published last month in the Journal of the American Medical Association and on the USPSTF website — update a similar version published in 2013. They differ in that they now include an additional class of medication, aromatase inhibitors, on the list of drugs believed to help reduce women’s risk. (Aromatase inhibitors have not yet been approved by the Food and Drug Administration specifically for the purpose of preventing breast cancer.) Although their particular mechanisms vary, the breast cancer medicines recommended by the task force all work by lowering or blocking estrogen — a female hormone — to decrease breast cancer risk. The medication must be taken daily for a period of five years. RELATED: Speaking Genetics: A Glossary of Cancer Risk Gene Mutations A Track Record of Reducing Risk In 10 trials reviewed by the task force, all three types of drugs reduced invasive and ER-positive breast cancer but not ER-negative breast cancer. “If 1,000 women at higher risk took these medications for five years, you’d expect somewhere between 7 and 16 fewer cases of breast cancer,” says task force member Michael Barry, MD, medical director of the John D. Stoeckle Center for Primary Care Innovation at Massachusetts General Hospital in Boston. “Again, that’s out of 1,000, so it may seem like a small number,” he says. “But of course if you’re one of those women, it might be quite important.” The Challenge of Determining a Woman s Breast Cancer Risk The USPSTF stresses that the medication should be considered only for women whose odds of developing breast cancer are higher than average — but determining those odds is not always easy. Widely available risk-assessment models such as the Gail model, the first used clinically, weigh factors including (but not limited to) a woman’s age, whether she has first-degree relatives with breast cancer, and how old she was when she first got her period. But such tools are imperfect, and there is no single definition for what constitutes being at higher risk, according to the American Cancer Society. “Although there are a lot of models, they are very rough guidelines,” says Leif W. Ellisen, MD, PhD, program director of Breast Medical Oncology at Massachusetts General Hospital Cancer Center in Boston, who was not a member of the task force. “That’s challenge number one.” According to Dr. Ellisen, the second challenge for primary care providers is analyzing potential risk versus benefits of these medicines. “If we say, ‘Well, this could cut your risk for breast cancer in half if you just take the medicine for five years,’ that sounds pretty good. But if the woman’s risk is already quite low, it may not be very meaningful.” What’s more, the medication is not without side effects. Mild side effects include hot flashes, fatigue, and mood swings. More serious ones may include blood clots and other forms of cancer. Primary Care Physicians Often Don t Suggest the Drugs Many women who are at increased risk may never learn about the option of taking preventive medication. The task force notes that only 10 to 30 percent of primary care doctors say they have prescribed breast cancer prevention medication. And most of those say they have done so only a handful of times. “I do think most women have never heard of these,” says Mary B. Daly, MD, PhD, a professor in the department of clinical genetics at the Fox Chase Cancer Center in Philadelphia, who was not a member of the task force. “And I think prescribing them has never really been in the realm of primary care.” Dr. Daly advises patients with a family history of breast cancer to mention this to their doctors during the context of family history. Similarly, if a woman is concerned about other risk factors, such as dense breasts, she should mention it. “If their primary care doctor doesn’t feel comfortable discussing these [medications], a referral to a breast cancer risk specialist is indicated,” says Ellisen. NEWSLETTERS Sign up for our Cancer Care Newsletter SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy. The Latest in Breast Cancer How to Avoid Pink Ribbon Pitfalls During Breast Cancer Awareness Month Before you donate to a breast cancer organization this month, make sure you know where your money’s going. By Leona VaughnSeptember 30, 2022 Cancer Me and My Solo RaftBy Denise SchipaniSeptember 13, 2022 Targeted Therapies for Metastatic Breast Cancer— Here' s What You Should KnowThe latest treatments and therapy approaches for metastatic breast cancer are helping patients live longer and offering new hope.By Cheryl Platzman WeinstockSeptember 7, 2022 Struggling With Insomnia During Breast Cancer Treatment Here s How to DealBreast cancer treatment can bring about many sleepless nights. Here’s how to get your sleep schedule back on track.By Carolyn BernhardtSeptember 7, 2022 Finding Ways to Heal in a Complex Healthcare SystemWhen Theresa Brown, an oncology nurse, was diagnosed with breast cancer in 2017, she found herself on the receiving end of getting care. The experience...By Lambeth HochwaldSeptember 6, 2022 Navigating Breast Cancer Treatment as a Black WomanWhen Asha Miller was diagnosed with stage 3 breast cancer 4 years ago, she couldn’t find the support she needed as a Black woman going through the experience...By Kaitlin SullivanAugust 24, 2022 One Woman s Mission to Help African Immigrants Navigate Breast Cancer CareIfy Anne Nwabukwu wants immigrant women in the Washington, DC, area to know that help is just around the corner.By Lambeth HochwaldAugust 24, 2022 Cutting Into Breast Cancer Disparities With Genetic TestingCancer researcher Olufunmilayo I. Olopade, MD, says, 'In the next decade, I predict we’ll see this kind of optimized treatment become available for everyone...By Susan K. TreimanAugust 24, 2022 The Long Day Recovering From My MastectomyBy Denise SchipaniAugust 23, 2022 Olivia Newton-John Pop Singer and Star of Grease Dies at 73Newton-John was first diagnosed with breast cancer in 1992 and later became an advocate for breast cancer survivors.By Don RaufAugust 8, 2022 MORE IN Breast Cancer Symptoms Diagnosis and Stages Hormone Replacement Therapy Not Linked to Breast Cancer Recurrence Study Finds 20 Celebrities With Breast Cancer